Literature DB >> 2833958

The use of enzymopathic human red cells in the study of malarial parasite glucose metabolism.

E Roth1, V Joulin, S Miwa, A Yoshida, J Akatsuka, M Cohen-Solal, R Rosa.   

Abstract

The in vitro growth of Plasmodium falciparum malaria parasites was assayed in mutant red cells deficient in either diphosphoglycerate mutase (DPGM) or phosphoglycerate kinase (PGK). In addition, cDNA probes developed for human DNA sequences coding for these enzymes were used to examine the parasite genome by means of restriction endonuclease digestion and Southern blot analysis of parasite DNA. In both types of enzymopathic red cells, parasite growth was normal. In infected DPGM deficient red cells, no DPGM activity could be detected, and in normal red cells, DPGM activity declined slightly in a manner suggestive of parasite catabolism of host protein. However, in infected PGK deficient red cells, there was a 100-fold increase in PGK activity, and in normal red cells, a threefold increase in PGK activity was observed. Parasite PGK could be recovered from isolated parasites, and a marked increase in heat instability of parasite PGK as compared with the host cell enzyme was noted. Neither cDNA probe was found to cross-react with DNA sequences in the parasite genome. It is concluded that the parasite has no requirement for DPGM, and probably has no gene for this enzyme. On the other hand, the parasite does require PGK, (an adenosine triphosphate [ATP] generating enzyme) and synthesizes its own enzyme, which must have been encoded in the parasite genome. The parasite PGK gene most likely lacks sufficient homology to be detected by a human cDNA probe. Enzymopathic red cells are useful tools for elucidating the glycolytic enzymology of parasites and their co-evolution with their human hosts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833958

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro.

Authors:  Inês Morais; Márcia M Medeiros; Maria Carvalho; Judit Morello; Sara M Teixeira; Suelma Maciel; Janice Nhantumbo; Ana Balau; Margarida T G Rosa; Fátima Nogueira; João Alexandre Rodrigues; Filomena A Carvalho; Alexandra M M Antunes; Ana Paula Arez
Journal:  Front Cell Infect Microbiol       Date:  2022-03-15       Impact factor: 5.293

2.  A Bioinformatics Approach for Homology Modeling and Binding Site Identification of Triosephosphate Isomerase from Plasmodium falciparum 3D7.

Authors:  M Ullah; J Hira; T Ghosh; N Ishaque; N Absar
Journal:  J Young Pharm       Date:  2012-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.